Detalhe da pesquisa
1.
A pilot safety, feasibility and efficacy study of an oral anticoagulant, apixaban, in secondary prophylaxis of a primary venous thromboembolism in children and adolescents.
Br J Haematol
; 201(5): e54-e57, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37042190